Showing results (1131-1140 of 1,203) with videos related to

Sort By:
Pageof 121
The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Frontiers in Drug Safety and Regulation|January 14, 2026
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant womenEmeline Maisonneuve, Nicoletta Luxi, Chiara Bellitto, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 21, 2023
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohortGuillaume Favre, Emeline Maisonneuve, Léo Pomar, et al.
JAMA|September 23, 2010
Subclinical hypothyroidism and the risk of coronary heart disease and mortalityNicolas Rodondi, Wendy P J den Elzen, Douglas C Bauer, et al.
The Lancet. Haematology|December 25, 2017
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 studyCaroline Dartigeas, Eric Van Den Neste, Julie Léger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2015
Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control ConsortiumM Waterhouse, H A Risch, C Bosetti, et al.
Lancet (London, England)|October 9, 2007
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trialThierry Facon, Jean Yves Mary, Cyrille Hulin, et al.
Medical Oncology (Northwood, London, England)|November 29, 2018
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancerB A Jereczek-Fossa, A Maucieri, G Marvaso, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Establishment of a new human pneumococcal standard reference serum, 007spD Goldblatt, B D Plikaytis, M Akkoyunlu, et al.
Pageof 121